chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a healthcare professional on 10 November 2014. A female patient (age not reported) whose medical history and concomitant medication were not reported, received intramuscularly a dose of FLUZONE ID (batch number, expiry dose of vaccine and route of vaccination was not reported) in right arm on an unspecified date. On an unspecified date, patient experienced mark on arm at injections site. Patient stated that, she had personally administered 200 doses from the same lot number with no other c/o of injection site reaction. Corrective treatment and laboratory investigations were not reported. At the time of this report, the outcome of the event was reported as not recovered. Documents held by sender: none. Follow-up received from a consumer on 04 February 2015. A 46-year-old female patient had received 0.1 ml of FLUZONE ID, Batch number: UT4982BA in right deltoid in October 2014. Patient had not received any vaccination prior to four weeks and had no illness at the time of vaccination. The vaccine was purchased at private fund. The patient had no pre-existing physical-diagnosed allergies, birth defects, medical condition. It was reported that the event was caused by an administration error. At the time of this report the patient was not recovered from event. Documents held by sender: none.
Normal flu-like symptoms and fatigue at time of vaccinations. My real issue is that when having my quarterly checkup in July, my CBC indicated a SHARP drop in my Hemoglobin, Iron Saturation, Iron Serum and Ferritin levels. As of January 2022, the numbers are SLOWLY recovering - but NOT THE FERRITIN number. That remain at 7. My understanding is that it should be between 13 and 150.
Dose #3 administered at 2-3pm on 05/22/06.  Onset of symptoms at 8-9pm.  Soreness at injection site, nausea, headache.  Called MD.  MD did not address symptoms.  Contacted Public Health and Env Services.  Advised pt to again contact MD and ask them to report adverse event.  Other details related to vaccine administration unknown.
This spontaneous report was received from an office manager refers to an adult patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with pediatric dose of VAQTA (dose, frequency, lot number and expiry date were not reported) intramuscularly for prophylaxis (incorrect dose administered). The patient did not have adverse event. The outcome of incorrect dose administered and no adverse event was unknown.
Severe Tinnitus. Can't sleep as a result. All because of this vaccine. This is just sick.
Client awoke to find lips swollen, itchy throat tingling mouth, testicles swelled, generalized hives and itching. Went to physician received treatment to stop adverse effects of swelling, itching. Felt normal two days after receiving medical treatment.
1 week after receiving the COVID vaccine Moderna patient had a Hida scan; was given an IV with radioactive tracer in her left arm. On Saturday 1/30/2021 patient noticed a red spot around the injection site, underneath the bicep is red, hard & hot to the touch.  Painful to move arm.  Pain is radiating down to the elbow & up to the shoulder.
Mild vaginal burning beginning in the afternoon.  Continued to get worse the next few days.  OTC treatment.
Patient was given Flumist.  24 hours later had urticaria.  Lasted for 4 weeks and responded to conservative therapy.
Flu vacc 1-27-18. Started with sinus symptoms. Diagnosed with Flu 02-05-2018. Suffered 5 days with flu/ bronchitis/ fever x 5 days. Began feeling really ill 02-09-2018. Trouble walking, swallowing, severe stomach pain, hot cold flashes, irritable, lost interest drinking and eating, trouble brushing teeth, urinating, showering ( to painful) insomnia due to pain, extreme fatigue, deep excruciating pain that was much worse at night, unable to concentrate, to weak to get out of bed.
I am experiencing a lot  numbness and slight weakness in my left leg from above the knee to the bottom of my foot and toes
Severe localised Rx with redness/hardness and low grade temp Pt may have had pertussis in high school Treatment-with Advil and warm compress
Itching, blotches,  hives, discomfort. Did not improve with BENADRYL. Developed morning after day of shots. Seen in office on 9-7-11.
Early that morning I woke up seeing pink out of my left eye. I went to eye doctor and they found I had a mini stroke behind my left eye.
Within 48 hours of Prevnar, pt developed fever (105 R), irritability and poor PO. No other symptoms. Was admitted to hospital and diagnosed with probable viral syndrome.
Hard lump at injection site with redness and auxiliary swelling and pain beginning 5 days after injection
Pain, swelling under left arm progressing into left breast for about 2 weeks.  Intermittent, but increasing frequency ringing in both ears for over 1 year.   Strange extremely strong pressure sensation and unusual feeling of "hearing" heartbeat  up both sides of neck and head while exercising.
Narrative:  COVID infection following COVID vaccine series 02/21, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, diarrhea, dyspnea exposure: unknown 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE AY.25 08/31 SARS-COV-2 CLADE 21 J DELTA 09/01 pt admit to Medicine cc: cough and leg edema dx: covid 19 pneumonia LOS: 10 days 09/01 CXR impression: Bilateral airspace disease. Correlate clinically for pneumonia including viral/atypical etiology and follow-up to resolution 09/01 US extremity impression: 1. Right lower extremity: Findings suggestive of a subtle nonocclusive thrombus in the deep femoral vein. 2. Left lower extremity: Mild mural irregularity and echogenicity focally in the mid/distal femoral vein perhaps from a chronic nonocclusive thrombus 09/01 CTA PE impression: 1. No evidence of pulmonary embolism or dissection. 2. Patchy peripheral groundglass and consolidative opacities which can be seen with a history of Covid. 3. Stenosis of the left lung bronchi which is likely due to position however recommend contrast enhanced CT after resolution of acute infection. 4. Severe degenerative changes of the spine status post cervical and lumbar. Bones are diffusely osteopenic. Multiple compression fractures. The critical result of follow-up CT for bronchial stenosis was communicated to Dr. on 9/1/2021 at 21:07 with read-back verification. 09/01 PROCALCITONIN results: <0.05 09/01 DDIMER result: 0.74 09/02 CXR impression: Similar-appearing retrocardiac and right infrahilar opacities suspicious for pneumonia. 09/02 ESR result: 10 09/02 Fibrinogen result: 261 09/02 DDIMER result: 0.79 09/03 ESR result: 9 09/03 Fibrinogen result: 240 09/03 DDIMER result: 0.52 09/04 ESR result: 11 09/04 Fibrinogen result: 200 09/04 DDIMER result: 0.78 09/05 ESR result: 5 09/05 Fibrinogen result: 207 09/05 DDIMER result: 0.90 09/06 ESR result: 9 09/06 Fibrinogen result: 228 09/06 DDIMER result: 1.03 09/07 ESR result: 3 09/07 Fibrinogen result: 245 09/07 DDIMER result: 0.69 09/08 ESR result: 9 09/08 Fibrinogen result: 264 09/08 DDIMER result: 0.97 09/10 clinically resolved
Widespread itchy rash on my torso, arms, neck, head, legs, but not at the injection site. The vaccine was administered  at 8.30AM and the rash didn't appear until 10PM the same day. I am treating with antihistamines - Benadryl (nightime) and Claritin D (daytime).  I need to know if I should get the second dose or not .
We have tract patient's symptoms back to early part of December.  She complained on and off of achy joints and just not feeling right.  In February one of her track coach's approched me with concern and asked if patient had told me about her knees hurting and the lower part of her legs going numb on several different occasions.  The trainer had looked at her and suggested a knee brace.    The sparactic numbness continued though.  On 4-14-08 patient received the 3rd HPV vaccine.  On 4-18-08 I received a phone call that patient  had experience and ice pick type pain in the back of her head and could not see out of her right eye and was complaining that the  right side of face and arm were completely numb.  We went straight to Dr. who sent us to hospital for a cat scan and then to Emergency for and MRI. Diagnosis: Sphrenoid Sinusitis.  She was given a prescription for a Z-pack and Naprolan. Patient's symptoms seem to improve but still complained of achy joints especially in her lower back and hips and now experiencing twitching on the right side of face and arm.  On 5-7-08 we took patient to the emergency room again because her lower back, hips, knees and ankles were hurting and numb. She complained that the pain felt like it was coming from the inside of the bone.  Diagnosis:  Possible pinch nerve, ice and heat along with Advil were to be implemented  5-8-08 I called Dr. because patient's symptoms had worsened overnight and now was having trouble walking.  He called an nueroligist and set up for him to see her 5-9-08 the very next morning at 6:30a.m..  Dr. examined patient and told us he was admitting her into the hospital with the suspicions of MS.  He treated her symptons as and MS patient.  A spinal tap, MRI, and blood work was ordered along with and IV for a steroid treatment to be given every 6 hrs. for 30 mins each time.  Patient was discharged on 5-13-08 and to take Predizone for 5 days along with Aleeve.  On 5-20 Dr. did and EmG and found  left lumzosacarl radiculopathy.  Dr. referred us to Pediactric neorologist.  6-17 Dr. examined and order an Evoke Potential findings were normal.  Patient continues to have sparatic numbness, achy joints especially hips and knees, and lower back pain.  From November to May patient's symptons gradually escalated.  As of today, patient is still experiencing sparactic espisodes and is taking Aleeve everyday to manage her pain.  We are still in the process of finding out how to help her and the actual cause. A Pediactric Rhumatologist from Hospital is reviewing her reports.  We are waiting to here back from them. 8/15/08-records received for DOS 5/9-5/13/08- presented with C/O progressive weakness of left lower extremity with some back pain radiating down into lower extremity. Hip and joint pain. Rheumatoid arthritis ruled out. Admitted with presumed myelitis. Treated with IV Solu-Medrol and improved.
This spontaneous report as received from a licensed vocational nurse refers to a 12 year old male patient. The patient had no illness at time of vaccination. No information on patient's medical history or concomitant medications was provided. On 24-AUG-2015 at 01:43 PM, the patient was vaccinated with the second dose (reported as #1 given elsewhere) of (Oka/Merck) VARIVAX injection, lot # L010145, subcutaneously in the left arm (dose and expiration date were not reported) that was improperly stored. The patient's concomitant vaccines given on the same day and time included GARDASIL injection, lot # K011562, intramuscularly in the right arm (dose and expiration date were not provided). No adverse effects were reported.  This is one of the several reports from the same source. Additional information is not expected as all correspondence was received.
12/28 /2021 heach ache 12/29/2021  low grade fever of 100 12/30 joints 12/31/2021 low grade fever and joint pains and 01/01/2021 fever to 100.  joints had hips, knees and ankle ache pain and weakness and stiff on medication  Meloxicam 15 mg daily  for a week
Bad case of the chills followed by stiff joints, weakness and fever of 100 to 101.  Felt fine the next day, 03/12/04.
12 hours after injection severe chills, sweating, fever, insomnia.  Next day headache, loss of appetite, lethargy, brain fog.   Symptoms resolved 36 hours after injection.
fever,chills,erythema @ inj site lt deltoid/extending to chest&lt breast;tenderness lt upper arm axilla;area of erythema 7x12 cm;
red rash on the bottom of her stomach; red rash has shown up in other parts of her body like her right side of her lower back, right side of her hip, backside, and two spots on her thighs; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash on the bottom of her stomach) and RASH (red rash has shown up in other parts of her body like her right side of her lower back, right side of her hip, backside, and two spots on her thighs) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced RASH ERYTHEMATOUS (red rash on the bottom of her stomach) and RASH (red rash has shown up in other parts of her body like her right side of her lower back, right side of her hip, backside, and two spots on her thighs). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form and MICONAZOLE NITRATE (NEOSPORIN AF) at a dose of 1 dosage form. At the time of the report, RASH ERYTHEMATOUS (red rash on the bottom of her stomach) and RASH (red rash has shown up in other parts of her body like her right side of her lower back, right side of her hip, backside, and two spots on her thighs) had not resolved.            Action taken with mRNA1273 Moderna vaccine was Not Applicable  No concomitant medication was provided
fever 101.1 to 102.2; migraine/headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on an unspecified date as unknown, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date the patient experienced fever 101.1 to 102.2, slight headache and migraine. Patient called-in saying that she joined the clinical trial and there are some minor side effects such as fever 101.1 to 102.2 and slight headache which she considers normal because she is a migraine patient normally experiencing migraine every 20 to 25 days. She is also reporting that there is something today that happened wherein they are supposed to open the actual vaccination soon but they have opened today without her presence and this is very odd for her. A caller wants to understand the standard protocol because we are paying her. The event fever 101.1 to 102.2 was found to be medically significant. The patient underwent lab tests and procedures which included body temperature: 101.1 to 102.2 on unspecified date. The outcome of the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Wednesday and Thursday I only got 2 hours sleep which occurred Thursday early afternoon. I got the shot on Thursday morning 9/2/2021. My arm was very sore, swollen and red for 7 days all the way up to my shoulder and I had swelling in my right collarbone area which was the side I got the shot. It's still sore around the vaccination site. On Friday, 9/3/2021 I laid down to sleep at 11:00 a.m. and slept 33 hours. Every time I either had to get up to go to the bathroom or throw some food out for my cat I could barely stand up or walk. I felt queasy and had no appetite. My vision was blurry. I had COVID the end of March/beginning of April and the symptoms of the shot were the same as when I had COVID, except when I had it I slept non-stop for a longer period of time. A week after being diagnosed with COVID I had a monoclonal antibody infusion. That's why I had to wait three months before I could get the vaccine. The reason I didn't get the vaccine when the three months was up, was because I was in the process of moving and developed four infections at once and my doctor recommended waiting until I felt better before having the shot.
Patient reported acute pain in interior elbow area of left arm. About 25 minutes later she reported weakness in both legs (noodle-like feeling), but did not feel as if she was in danger of falling because of it.
RSV Bronchitis. ED visit and hospitalization. This visit is within 6 weeks of receiving the COVID vaccine.
One day post vax, the pt noted an erythematous, slightly raised tender to touch area on the right lateral arm at the injection site. Decreased movement of arm, pain and missed school. The pt also had an elevated temp as well. The area increased in sized until 11/16/00. On 11/17/00 was seen by MD. The area was approximately 7.5 cm x 7.0 cm.
Information has been received from physician concerning a 16 year old female with a sore arm to a horse riding internal injury who reported on 24-Oct-2007 that "2-3 weeks ago" she was vaccinated intramuscularly with the first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). Subsequently, "2-3 weeks ago", the patient developed little blisters around the injection site. The patient outcome was not reported. The patient did not think she would get the second or third dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). The patient did not seek medical attention. Additional information has been requested.
12/20/2020- 1st dose Moderna COVID-19 vaccine 01/28/20201- 2nd dose Moderna COVID-19 vaccine.  08/05/2021 - date of symptom onset 08/12/2021- patient tested positive for COVID-19.
Pt. presented with hives and became short of breath. Benedryl 50mg IM. Pt. signed AMA.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PYREXIA (fever), RASH ERYTHEMATOUS (red rash on arm going down from the injection site), VACCINATION SITE PAIN (sore) and VACCINATION SITE ERYTHEMA (red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 15-Mar-2021, the patient experienced PYREXIA (fever). On 16-Mar-2021, the patient experienced RASH ERYTHEMATOUS (red rash on arm going down from the injection site), VACCINATION SITE PAIN (sore), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (felt hot). On 17-Mar-2021, the patient experienced RASH (rash spread farther down arm), FEELING HOT (hot), PRURITUS (itchy), PAIN IN EXTREMITY (painful) and LYMPHOEDEMA (lymphedema). On an unknown date, the patient experienced RASH ERYTHEMATOUS (red). At the time of the report, PAIN IN EXTREMITY (Sore arm), PYREXIA (fever), RASH ERYTHEMATOUS (red rash on arm going down from the injection site), VACCINATION SITE PAIN (sore), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE WARMTH (felt hot), RASH (rash spread farther down arm), FEELING HOT (hot), RASH ERYTHEMATOUS (red), PRURITUS (itchy), PAIN IN EXTREMITY (painful) and LYMPHOEDEMA (lymphedema) outcome was unknown. Not Provided. Concomitant product use was not provided by the reporter. Treatment information included tylenol and antibiotics.
w/in 2hr of inj had red raised rash & hard lump & swelling @ site;tx w/ice pack;n day 10 devel rash on body & fever of >101-103.4 for 3 days;tx w/APAP;also lump/swell & bruise;resolved in about 2wk;bruise encircled the extremity;
Digestive issues - started with bloating where I experienced difficulty taking a full breath. That caused anxiety and panic. After visiting urgent care and my PCP I made changes to my diet. After making significant lifestyle changes and changes to my diet (cutting out sugar) I've been feeling brain fog, fatigue, and insomnia (trouble staying asleep, no issues falling asleep)
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs were reported.  Reporter stated that no treatment was given to the patients. Reporter stated that vaccine was stored in freezer and took out one or two vials. The vails were placed in fridge as needed.
Body/bone aches, sore throat, tender glands, headache, fever (highest was 101.8). On 10/25 I went to immediate care center. They were not sure if reaction to vaccine or virus. Strep screen was done with negative results. Today, 10/26, I have no fever and feeling much better.
No additional adverse events reported; One unspecified patient received a dose of PNEUMOVAX 23 that was improperly stored; Information has been received from a pharmacist regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 25-SEP-2020, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection as prophylaxis (lot number T00974 with expiration date on 28-JAN-2022) (dose, frequency scheme, route of administration and anatomical location were not reported).  It was reported that pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) experienced a temperature excursion at a temperature range of 49.1 degrees Fahrenheit (F) for the time frame of 12 hours. There was no previous temperature excursion and the call was because of a data logger. No additional adverse effects reported.  Lot number T00974 is an invalid lot number for pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23).  Follow-up information has been received from the pharmacist on 15-DEC-2020.  It was reported that the patient was a 77-year-old male. His medical conditions included high blood pressure. The reported did not know of any other medications that patient was taking. On 25-SEP-2020, he was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) intramuscularly in the left deltoid (lot # T009744 has been verified to be valid, expiration date reported and validated as 28-JAN-2022) (dose number, dose and frequency scheme were not reported). Additionally, he received a dose of influenza virus split virion 4v vaccine inactivated (FLUZONE HD).  It was reported that the patient was fully recovered from the adverse event. He was vaccinated at a pharmacy and the vaccine was purchased with private funds.  This is one of two reports received from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T009744; expirationdate: 28-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other;  followupadditionalinfo :Yes; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2012USA007563:
Warm, red, swelling and local tenderness which progressed down arm below elbow. Treatment: Augmentin 500mg T1D X 10 days.